[EXPERIMENTAL STUDIES AND CLINICAL USE OF ELECTROLYTE-CARRIER COMPOUNDS. 6. ORIENTATIONAL RESEARCH ON MAGNESIUM- AND POTASSIUM-NICOTINYL-ASPARAGINATE (MG + K - NA)].
Explore the source record for details and available documents.
Asparagine↗
Biomedical subjects
H A NIEPER
Publications and source records attributed to H A NIEPER.
[THE DEVELOPMENT AND TESTING OF FUNGISTATIC COMPOUNDS. FOR THE TREATMENT OF CANCER].
Explore the source record for details and available documents.
Animals↗
[Determination of residual nitrogen according to the Rappaport-Riechert method with nomographic evaluation].
Explore the source record for details and available documents.
Nitrogen↗
[The development and evaluation of fungistatic compounds in the treatment of cancer. 2].
Explore the source record for details and available documents.
Antifungal Agents↗
[Experimental bases and clinical uses of electrolyte-carrier compounds. 5. Orientational studies on potassium- and magnesium-2-aminoethanol phosphate (EAP)].
Explore the source record for details and available documents.
Alcohols↗
[The development and evaluation of fungistatic compounds in the treatment of cancer. I].
Explore the source record for details and available documents.
Antifungal Agents↗
[Electrolyte carriers in experiments, laboratories and clinical practice. (II). Active ion transport therapy].
Explore the source record for details and available documents.
Electrolytes↗
[Electrolyte carriers in experiments, laboratories and clinical practice. (I). Active ion transport therapy].
Explore the source record for details and available documents.
Electrolytes↗
[Experimental principles and clinical use of electrolyte carrier compounds. 3. The normalizing effect of magnesium and potassium asparaginate on an atypical substrate balance appearing after prolonged treatment with digitoxin].
Explore the source record for details and available documents.
Asparagine↗
[Experimental principles and clinical use of electrolyte carrier compounds. 4. The normalizing effect of potassium and magnesium asparaginate on an atypical substrate balance appearing in cancer patients. The importance of the problem for the host organism].
Explore the source record for details and available documents.
Asparagine↗
[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment].
Explore the source record for details and available documents.
Asparagine↗
[Experimental basis and clinical use of electrolyte carrier compounds. I. Metabolic activity of Mg- and K-asparaginate, especially in coronary insufficiency].
Explore the source record for details and available documents.
Asparagine↗
[The effectiveness of electrolyte carrier compounds on myocardial metabolism, illustrated by magnesium and potassium asparaginate].
Explore the source record for details and available documents.
Asparagine↗
[Therapy of leukopenia and hypercholesterinemia with magnesium compounds].
Explore the source record for details and available documents.
Antacids↗
[Physiological principles and indications for magnesium therapy].
Explore the source record for details and available documents.
Magnesium↗
[Experimental & theoretical bases of immune biology & theory of pathogenicity of cancer].
Explore the source record for details and available documents.
Biology↗
[Janus green stainability of corpuscles occurring enclosed in erythrocytes in cancer].
Explore the source record for details and available documents.
Azo Compounds↗
[Lack of carcinogenic effect of Janus green for rats].
Explore the source record for details and available documents.
Animals↗